4 percent of those aged 65+ have dementia diagnoses: report
By
Kimberly Bonvissuto
Jun 14, 2024
Four percent of US adults aged 65 or more years have a dementia diagnosis, with rates of dementia increasing with age, according to newly released data.
Lifestyle intervention can improve cognition, function in early Alzheimer’s disease
Jun 13, 2024
A significant correlation was seen between lifestyle and both cognitive function and Aβ42/40 ratio.
FDA advisers support new Alzheimer’s drug
Jun 11, 2024
A US Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer’s outweigh its harms, which can include brain swelling and...
Navigating insurance for those with dementia a major challenge for family caregivers
By
Kathleen Steele Gaivin
Jan 30, 2024
Family caregivers face many challenges in helping their loved ones who are living with dementia, not the least of which is navigating the insurance landscape for long-term care. That’s according to the...
Assisted living mental health services fell between 2019 and 2020, study finds
By
Kristen Fischer
Apr 25, 2024
Mental health visits for assisted living residents living with dementia dropped as the pandemic set in, a new study finds.
UCSF telehealth program cuts costs and improves outcomes for seniors with dementias
By
Aaron Dorman
Sep 25, 2023
A telehealth program out of UCSF has achieved the coveted goal of cutting costs and improving patient care for seniors with dementia, researchers state.
Advocates ‘appalled’ as CMS again says it will not cover monoclonal antibody treatments for Alzheimer’s
By
Kimberly Bonvissuto
Feb 24, 2023
Advocates of those living with Alzheimer’s disease are expressing disappointment that the Centers for Medicare & Medicaid Services on Wednesday rejected a request to expand its coverage of monoclonal...
CMS announces Alzheimer’s drug coverage policy, but ‘the devil is in the details,’ experts say
By
Kimberly Bonvissuto
Jun 01, 2023
A Thursday announcement by the Centers for Medicare & Medicaid Services regarding coverage of Alzheimer’s drugs is being met with skepticism by some industry advocates who say that “the devil is in...
Lawmakers turn up heat on CMS to expand access to Alzheimer’s treatments
By
Kimberly Bonvissuto
Apr 28, 2023
Medicare needs to reconsider its national coverage decision on FDA-approved Alzheimer’s drug treatments, bipartisan members of the House told Centers for Medicare & Medicaid Services Administrator Chiquita...
More news for Wednesday, Feb. 22
By
Kimberly Bonvissuto
Feb 22, 2023
Congressman tells AG Garland that Esformes case is ‘political’ … FHCA unveils 2023 legislative priorities … Medicare advisers suggest tweak to coverage process for Alzheimer’s drugs … Schumer...